Drugs Made In America Acquisition Corp. is a blank check company, which engages in the provision of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The company is headquartered in Fort Lauderdale, Florida. The company went IPO on 2025-01-28. The firm is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The firm intends to focus its search for businesses in the pharmaceutical industry. The firm has neither engaged in any operations nor generated any revenues.
DMAAU stock price ended at $10.58 on 水曜日, after rising 1.44%
On the latest trading day Apr 08, 2026, the stock price of DMAAU rose by 1.44%, climbing from $10.57 to $10.58. During the session, the stock saw a volatility of 0.09%, with prices oscillating between a daily low of $10.57 and a high of $10.58. Notably, trading volume dropped by 2.8K shares on the last day despite the price increase, which may signal a potential uptick in risk in the near term. A total of 2.9K shares were traded, equating to a market value of approximately $354.6M.
¿Cómo se aplican los indicadores de análisis técnico a DMAAU?
Según el análisis técnico, Drugs Made In America Acquisition Corp tiene una señal agregada de Strong Buy. Drugs Made In America Acquisition Corp tiene 5 señales de compra, 2 señales neutrales y 0 señales de venta.
¿Cuáles son los niveles de retroceso de Fibonacci para DMAAU?
El nivel de retroceso de Fibonacci de Drugs Made In America Acquisition Corp es 0%水準より上。
¿Cuál es el RSI de Drugs Made In America Acquisition Corp?
El RSI de Drugs Made In America Acquisition Corp es actualmente 60.03, lo que indica una condición 中立
¿Cuál es el precio de Drugs Made In America Acquisition Corp para los próximos 12 meses?
El precio de Drugs Made In America Acquisition Corp DMAAU para los próximos 12 meses se estima en $0.
¿Hasta dónde se espera que suba Drugs Made In America Acquisition Corp?
Según los analistas de Wall Street, se espera que Drugs Made In America Acquisition Corp alcance una previsión alta de $0.